REFERENCES
- Palella FJJ, Chmiel JS, Moorman AC, Holmberg SD. Du-rability and predictors of success of highly active antiret-roviral therapy for ambulatory HIV-infected patients. AIDS. 2002;16(12):1617–1626.
- Maggiolo F, Ripamonti D, Arici C, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials. 2002;3(5):371–378.
- Johnson M, Grinsztejn B, Rodriguez C, et al. Atazana-vir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures. AIDS. 2005;19(7):685–694.
- Johnson M, Grinsztejn B, Rodriguez C, et al. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures. AIDS. 2006;20(5):711–718.
- Pugliese P, Cuzin L, Enel P, et al. NADIS 2000, développe-ment d'un dossier medical informatisé pour les patients infectés par VIH, VHB et VHC. Presse Med. 2003;32:299–303.
- Ofotokun I, Chuck S, Hitti J. Antiretroviral pharmacoki-netic profile: a review of sex differences. Gender Med. 2007;4(2):106–119.
- Clark R. Sex differences in anti retroviral therapy-associated intolerance and adverse events. Drug Saf. 2005;28(12): 1075–1083.
- Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44:499–523.
- Collazos J, Asensi V, Carton JA. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS. 2007;21(7): 835–843.
- Moore T, Cohen M, Furberg C. Serious adverse drug events reported to the food and drug administration, 1998-2005. Arch Intern Med. 2007;167(16):1752–1759.
- Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887–1892.
- Gandhi M, Ameli N, Bacchetti P, et al. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005;19(16):1885–1896.
- Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. Euro-SIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 1999;13(15):2075–2082.